+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Smart Biopsy Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Smart Biopsy Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Smart Biopsy Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011802
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Smart Biopsy Devices Market grew from USD 5.49 billion in 2024 to USD 5.85 billion in 2025. It is expected to continue growing at a CAGR of 6.35%, reaching USD 7.95 billion by 2030.

The integration of advanced imaging, precision engineering and data analytics has ushered in a new era for tissue sampling. As minimally invasive procedures become the standard of care, smart biopsy devices are transforming how clinicians detect, characterize and manage cancer. By embedding sensors, leveraging real-time guidance and incorporating AI-driven decision support, these next-generation platforms are improving diagnostic yield, reducing patient discomfort and optimizing clinical workflows. This evolution responds to growing demand for early and accurate detection, driven by demographic shifts, rising cancer incidence and an emphasis on personalized medicine. Against this backdrop, stakeholders across the ecosystem-device manufacturers, healthcare providers and regulators-face both opportunities and challenges. Navigating regulatory complexities, ensuring interoperability and managing cost pressures while fostering innovation are critical to sustaining momentum. This executive summary examines the key trends, segmentation insights, regional dynamics, competitive landscape and strategic imperatives shaping the smart biopsy device market today.

Transformative Shifts Driving Next-Gen Biopsy Technologies

Over the past five years, several transformative shifts have redefined the biopsy device landscape. First, the proliferation of AI-powered imaging analysis has enhanced lesion targeting accuracy, reducing false negatives and repeat procedures. Concurrently, robotic assistance has advanced from prototype stages to clinical adoption, enabling submillimeter precision and consistent needle placement. In parallel, the convergence of multi-modal imaging-combining ultrasound, MRI and CT-has driven hybrid platforms that streamline pre-procedural planning and intra-operative guidance. Meanwhile, the shift toward minimally invasive sampling is accelerating adoption of vacuum-assisted and fine needle aspiration techniques, which deliver high-quality specimens while minimizing trauma.

Moreover, digital connectivity and cloud-based ecosystems now allow remote collaboration between radiologists, pathologists and interventionalists, enhancing diagnostic consensus and workflow efficiency. Regulatory agencies have responded by crafting guidelines that emphasize safety, data security and post-market surveillance, creating a more defined path for innovators. Finally, patient empowerment, fueled by telehealth and direct-to-consumer engagement, is raising expectations for transparency and comfort, prompting device makers to prioritize ergonomic design and real-time feedback. Together, these shifts form the foundation for smarter, safer and more effective biopsy solutions.

Evaluating the 2025 US Tariff Effects on Biopsy Device Markets

In 2025, newly implemented tariffs on imported medical devices and components in the United States have exerted a cumulative impact on procurement costs and supply chain dynamics. Tariffs imposed on key raw materials such as stainless steel and specialized polymers have raised production expenses for both domestic manufacturers and international suppliers. Consequently, device list prices have increased, placing pressure on hospital budgets and outpatient facilities to justify capital expenditures. Parallel restrictions on accessory imports have created bottlenecks in reagent availability and forced some organizations to seek alternative vendors or stockpile critical supplies, disrupting just-in-time inventory models.

These trade measures have also prompted strategic realignment, with several leading manufacturers considering localized production or near-shoring of assembly operations to mitigate duty burdens. While such moves can diminish long-term tariff exposure, they require significant investment in infrastructure and workforce training. Reimbursement schemes have adapted by adjusting payment rates to reflect changing cost structures, yet disparities remain across states, affecting device adoption rates. Overall, the 2025 tariff regime has introduced new cost layers and operational complexities that stakeholders must address through supply chain diversification, strategic sourcing and ongoing policy advocacy.

In-Depth Segmentation Analysis of the Biopsy Device Landscape

The biopsy device market exhibits nuanced behaviors when analyzed through multiple segmentation lenses. Based on product types, adoption patterns vary from brush biopsy devices, favored for superficial lesions, to core needle and excisional devices used in deeper tissue sampling, with vacuum-assisted systems gaining traction for high-yield breast and liver applications. Application segmentation reveals that breast cancer diagnostics remain the largest end-use domain, closely followed by lung and colorectal cancer diagnostics, while skin cancer detection-split between melanoma and non-melanoma assessments-drives innovation in handheld and point-of-care platforms. End-user analysis highlights that hospitals and clinics account for the majority of procedures, although ambulatory surgical centers are capturing share owing to cost efficiencies, and research institutes are increasingly deploying advanced devices for clinical trials.

Technology segmentation underscores the rapid growth of ultrasound-guided biopsies, both conventional and high-intensity focused variations, as they offer real-time visualization without ionizing radiation; CT-guided and MRI-guided approaches continue to serve complex anatomies, while stereotactic-guided and robot-assisted modalities expand precision in breast and prostate sampling. Material type distinctions between disposable and reusable devices influence purchasing decisions based on infection control protocols and total cost of ownership, with single-use systems preferred in high-volume centers. Cancer stage segmentation shows that Stage 0 through Stage II cases dominate screening and early detection applications, whereas Stage III and IV sampling drives demand for core needle and excisional techniques to inform therapeutic planning. Finally, sales channel segmentation illustrates that direct sales teams maintain close ties with key accounts, distributors and retailers extend geographic reach, and online sales platforms are emerging for consumables and smaller devices.

Regional Dynamics Shaping Global Biopsy Device Adoption

Regional dynamics exert a profound influence on adoption rates, reimbursement frameworks and regulatory pathways. In the Americas, strong investment in cancer screening programs, coupled with well-established reimbursement mechanisms for image-guided procedures, sustains robust demand for advanced biopsy platforms. Meanwhile, regulatory approvals tend to follow FDA clearances, enabling rapid market entry for proven technologies. In Europe, Middle East & Africa, heterogeneity in healthcare systems creates a patchwork of reimbursement policies and approval timelines; Western Europe leads in technology adoption given centralized funding and structured cancer registries, whereas emerging markets in the Middle East & Africa prioritize cost-effective, portable devices to expand diagnostic reach. Asia-Pacific displays diverse trends, with Japan and Australia exhibiting high penetration of robot-assisted and MRI-guided systems, while China and India focus on scaling minimally invasive, ultrasound-based solutions driven by large patient volumes and national screening initiatives. Cross-regional partnerships and local manufacturing collaborations are increasingly common strategies to navigate variable market entry barriers and align with regional procurement priorities.

Leading Industry Players and Their Strategic Trajectories

Competitive intensity in the biopsy device sector is shaped by the interplay of established medical technology leaders, specialized innovators and emerging disruptors. Becton, Dickinson and Company leverages its broad portfolio of sample collection tools while Boston Scientific Corporation continues to refine its core needle and vacuum-assisted systems with integrated imaging. C. R. Bard, Inc. focuses on ergonomic design enhancements and disposability features to streamline workflows. Canon Medical Systems Corporation and Medtronic PLC are differentiating through hybrid imaging-guided platforms that blend CT, ultrasound and MRI modalities. Cook Group Incorporated and Olympus Corporation emphasize endoscope compatibility and end-user training programs to drive device familiarity and loyalty.

On the diagnostic front, CytoGen, Inc. and Inivata harness liquid biopsy insights to complement tissue sampling, whereas Danaher Corporation and Innomedicus AG pursue strategic acquisitions to expand into adjacent diagnostic segments. Inrad Inc. and Interventional Systems invest heavily in software integration and tele-collaboration suites to facilitate remote expert consultation. PLANMED OY and TSK Laboratory Europe B.V. capitalize on niche device applications, such as high-intensity focused ultrasound and automated specimen processing. Across the board, these companies are aligning R&D pipelines, pursuing regulatory approvals in key markets and forging strategic partnerships to accelerate market penetration and enhance the clinical value proposition of their biopsy solutions.

Strategic Recommendations for Biopsy Device Market Leadership

To thrive amid evolving market dynamics, industry leaders should adopt a multifaceted strategy. First, prioritize interoperability by designing devices with open-architecture software that integrates seamlessly into electronic medical record systems and imaging networks, which enhances clinical adoption and data continuity. Second, invest in localized manufacturing or assembly hubs to mitigate tariff exposure and reduce lead times, while cultivating partnerships with regional distributors for efficient market access. Third, accelerate regulatory submissions through robust clinical evidence generation and early dialogue with approval agencies to streamline global launches. Fourth, strengthen value-based propositions by documenting patient-centric outcomes-such as reduced procedure times, fewer complications and lower total cost of care-to align with payor expectations. Finally, foster collaborative ecosystems by co-developing solutions with leading academic centers and thought leaders, ensuring that product roadmaps address unmet clinical needs and reflect real-world workflow constraints.

Concluding Perspectives on the Future of Biopsy Devices

The smart biopsy device market stands at an inflection point where technological innovation, regulatory evolution and shifting procurement models intersect. Leaders who navigate this complexity with agility-by embracing digital integration, refining cost structures and deepening clinical partnerships-will shape the standard of care for tissue sampling in the coming decade. Continuous investment in R&D, coupled with strategic market entry planning and rigorous evidence generation, will differentiate winning platforms. As healthcare systems worldwide grapple with rising cancer burdens and constrained resources, devices that deliver reliable diagnostics, minimize patient risk and support streamlined workflows will emerge as indispensable tools for oncologists and interventional radiologists. The interplay of segmentation nuances, regional dynamics and competitive pressures mandates a holistic approach to portfolio management and commercialization strategies.

Market Segmentation & Coverage

This research report categorizes the Smart Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Brush Biopsy Devices
  • Core Needle Biopsy Devices
  • Excisional Biopsy Devices
  • Fine Needle Aspiration Biopsy Devices
  • Punch Biopsy Devices
  • Vacuum-Assisted Biopsy Devices
  • Breast Cancer Diagnostics
  • Colorectal Cancer Diagnostics
  • Kidney Cancer Diagnostics
  • Liver Cancer Diagnostics
  • Lung Cancer Diagnostics
  • Prostate Cancer Diagnostics
  • Skin Cancer Diagnostics
    • Melanoma Detection
    • Non-Melanoma Skin Cancer
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Research Institutes
  • CT-Guided Biopsy
  • MRI-Guided Biopsy
  • Robot-Assisted Biopsy
  • Stereotactic-Guided Biopsy
  • Ultrasound-Guided Biopsy
    • Conventional Ultrasound
    • High-Intensity Focused Ultrasound (HIFU)
  • Disposable Biopsy Devices
  • Reusable Biopsy Devices
  • Stage 0 (Carcinoma In Situ)
  • Stage I
  • Stage II
  • Stage III
  • Stage IV
  • Direct Sales
  • Distributors and Retailers
  • Online Sales

This research report categorizes the Smart Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Smart Biopsy Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Canon Medical Systems Corporation
  • Cook Group Incorporated
  • CytoGen, Inc.
  • Danaher Corporation
  • Inivata
  • Innomedicus AG
  • Inrad Inc.
  • Interventional Systems
  • Medtronic PLC
  • Olympus Corporation
  • PLANMED OY
  • TSK Laboratory Europe B.V.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Smart Biopsy Devices Market, by Product Types
8.1. Introduction
8.2. Brush Biopsy Devices
8.3. Core Needle Biopsy Devices
8.4. Excisional Biopsy Devices
8.5. Fine Needle Aspiration Biopsy Devices
8.6. Punch Biopsy Devices
8.7. Vacuum-Assisted Biopsy Devices
9. Smart Biopsy Devices Market, by Applications
9.1. Introduction
9.2. Breast Cancer Diagnostics
9.3. Colorectal Cancer Diagnostics
9.4. Kidney Cancer Diagnostics
9.5. Liver Cancer Diagnostics
9.6. Lung Cancer Diagnostics
9.7. Prostate Cancer Diagnostics
9.8. Skin Cancer Diagnostics
9.8.1. Melanoma Detection
9.8.2. Non-Melanoma Skin Cancer
10. Smart Biopsy Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Diagnostic Laboratories
10.4. Hospitals and Clinics
10.5. Research Institutes
11. Smart Biopsy Devices Market, by Technology
11.1. Introduction
11.2. CT-Guided Biopsy
11.3. MRI-Guided Biopsy
11.4. Robot-Assisted Biopsy
11.5. Stereotactic-Guided Biopsy
11.6. Ultrasound-Guided Biopsy
11.6.1. Conventional Ultrasound
11.6.2. High-Intensity Focused Ultrasound (HIFU)
12. Smart Biopsy Devices Market, by Material Types
12.1. Introduction
12.2. Disposable Biopsy Devices
12.3. Reusable Biopsy Devices
13. Smart Biopsy Devices Market, by Cancer Stage
13.1. Introduction
13.2. Stage 0 (Carcinoma In Situ)
13.3. Stage I
13.4. Stage II
13.5. Stage III
13.6. Stage IV
14. Smart Biopsy Devices Market, by Sales Channel
14.1. Introduction
14.2. Direct Sales
14.3. Distributors and Retailers
14.4. Online Sales
15. Americas Smart Biopsy Devices Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Smart Biopsy Devices Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Smart Biopsy Devices Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Becton, Dickinson and Company
18.3.2. Boston Scientific Corporation
18.3.3. C. R. Bard, Inc.
18.3.4. Canon Medical Systems Corporation
18.3.5. Cook Group Incorporated
18.3.6. CytoGen, Inc.
18.3.7. Danaher Corporation
18.3.8. Inivata
18.3.9. Innomedicus AG
18.3.10. Inrad Inc.
18.3.11. Interventional Systems
18.3.12. Medtronic PLC
18.3.13. Olympus Corporation
18.3.14. PLANMED OY
18.3.15. TSK Laboratory Europe B.V.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SMART BIOPSY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. SMART BIOPSY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. SMART BIOPSY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SMART BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SMART BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMART BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BRUSH BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY EXCISIONAL BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PUNCH BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COLORECTAL CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY KIDNEY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LUNG CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MELANOMA DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY NON-MELANOMA SKIN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CT-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ROBOT-ASSISTED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY STEREOTACTIC-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DISPOSABLE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REUSABLE BIOPSY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY STAGE 0 (CARCINOMA IN SITU), BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY STAGE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY STAGE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY STAGE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY STAGE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 80. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 81. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 82. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 85. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 86. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 87. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 94. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 95. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 127. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 128. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 132. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 133. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 134. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 136. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 137. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 138. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 141. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 142. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 143. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 154. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 156. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 159. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 160. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 161. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 208. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 209. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 210. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 213. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 214. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 215. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 222. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 223. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 235. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 237. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 238. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 241. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 242. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 243. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 245. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 250. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 251. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 252. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 254. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 255. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 256. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 259. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 260. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 261. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 263. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 264. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 265. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 268. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 269. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 270. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 272. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 273. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 274. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 277. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 278. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 279. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 290. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 291. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 292. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 295. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 296. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 297. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 317. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 318. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 319. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 322. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 323. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 324. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 326. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 327. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 328. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 331. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY MATERIAL TYPES, 2018-2030 (USD MILLION)
TABLE 332. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY CANCER STAGE, 2018-2030 (USD MILLION)
TABLE 333. POLAND SMART BIOPSY DEVICES

Companies Mentioned

  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Canon Medical Systems Corporation
  • Cook Group Incorporated
  • CytoGen, Inc.
  • Danaher Corporation
  • Inivata
  • Innomedicus AG
  • Inrad Inc.
  • Interventional Systems
  • Medtronic PLC
  • Olympus Corporation
  • PLANMED OY
  • TSK Laboratory Europe B.V.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Bronchoscopic Biopsy Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Bronchoscopic Biopsy Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Bronchial Biopsy Devices Market Size, Share and Trends Analysis Report by Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), and Region 2024-2030 - Product Image

Bronchial Biopsy Devices Market Size, Share and Trends Analysis Report by Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Biopsy Devices Market by Product (Core Needle Biopsy (Automatic, Disposable), Technology (Ultrasound,Stereotactic), Application (Oncology, Gastroenterology, Bone & Bone Marrow Biopsy), End User (Diagnostic Imaging Centres) - Global Forecast to 2030 - Product Image

Biopsy Devices Market by Product (Core Needle Biopsy (Automatic, Disposable), Technology (Ultrasound,Stereotactic), Application (Oncology, Gastroenterology, Bone & Bone Marrow Biopsy), End User (Diagnostic Imaging Centres) - Global Forecast to 2030

  • Report
  • 504 Pages
  • Global
From
Smart Biopsy Devices Market Report 2025 - Product Image

Smart Biopsy Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Smart Biopsy Device Market

The Smart Biopsy Device market is a subset of the Medical Devices industry. It is composed of products that are used to diagnose and treat diseases and medical conditions. Smart Biopsy Devices are used to collect tissue samples from a patient for further analysis. These devices are designed to be minimally invasive and provide accurate results. They are used in a variety of medical procedures, such as cancer diagnosis and treatment. Smart Biopsy Devices are becoming increasingly popular due to their accuracy and ease of use. The Smart Biopsy Device market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include Medtronic, Stryker, Olympus, and Hologic. Other companies in the market include Becton Dickinson, Cook Medical, and Boston Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.